Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study.
| Image |  |
|---|---|
| Description | scientific article published on 14 October 2015 |
| Author/s |
author: Koji Oba Takao Takahashi |
| Publication date | October 14, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |